What happens next in GLP-1 — and when.

Get the briefing

What moved in the GLP‑1 field, in your inbox.

@glp1briefing

IndicationsPrediabetes › liraglutide

liraglutide in prediabetes

liraglutide is not approved in the US for prediabetes, and has 10 trials on file here in this condition. 7 of them are phase 3 or later. No trial here has a completion date still in the future, so this is a closed body of work rather than an active programme. Being studied in a condition is not the same as being approved for it; most such programmes end without an approval.

10 registered trials study liraglutide (Victoza, Xultophy, Saxenda) in prediabetes. None has a scheduled reporting date on file.

Trials on file
10
Active
0
Active phase 3
0
Participants in active trials
0
Sponsors
9
Scheduled readouts
0

All trials on file

Every registered trial of liraglutide grouped under prediabetes, largest first. Grouping follows the registry’s own condition wording.

TrialStatusPhaseSponsor
Improving Beta Cell Function in Mexican American Women With Prediabetes
NCT02488057
CompletedP4Ohio State University
Cardiovascular Effects of GLP-1 Receptor Activation
NCT03101930
CompletedP4Vanderbilt University Medical Center
RISE Adult Medication Study
NCT01779362
CompletedP3RISE Study Group
Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
NCT01234649
CompletedP3Woman's
Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?
NCT01845259
UnknownP2Psychiatric Centre Rigshospitalet
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
NCT02403284
CompletedP4Phoenix VA Health Care System
Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
NCT03480022
CompletedP3Woman's
Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.
NCT01784965
CompletedP3Stanford University
Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study
NCT02472717
WithdrawnP2University Health Network, Toronto
The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure
NCT02284230
WithdrawnP2Bo Feldt-Rasmussen

See the full record for liraglutide, or every molecule being studied in prediabetes. These are registered trials, nothing more. Most drugs tested in a new condition never get approved for it, and plenty of these will report nothing useful.